Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors in the
contemporary era, representing a significant global health concern. Early HCC patients have …

Cancer, as leading cause of death, has a high rate of mortality worldwide. Although there is
a wide variety of conventional approaches for the treatment of cancer (such as surgery and …

Cancer therapy is constantly evolving, with a growing emphasis on targeted and efficient
treatment options. In this context, graphene quantum dots (GQDs) have emerged as …

Proteins have emerged as promising therapeutics in oncology due to their great specificity.
Many treatment strategies are developed based on protein biologics, such as …

Ferroptosis is a promising strategy for cancer therapy because of its distinct reaction
mechanism and potential for overcoming cancer drug resistance. However, the efficient …

Intratumoral delivery and localized chemotherapy have demonstrated promise in tumor
treatment; however, the rapid drainage of therapeutic agents from well-vascularized tumors …

Despite advancements in cancer treatments, therapies frequently exhibit high cytotoxicity,
and surgery remains the predominant method for treating most solid tumors, often with …

The programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) immune checkpoint
constitutes an inhibitory pathway best known for its regulation of cluster of differentiation 8 …

Docetaxel (DTX) is a recommended treatment in patients with metastasic prostate cancer
(PCa), despite its therapeutic efficacy is limited by strong systemic toxicity. However, in …

Abstract mRNA therapeutics is revolutionizing the treatment concepts toward many diseases
including cancer. The potential of mRNA is, however, frequently limited by modest control …